A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
NCT ID: NCT00150267
Last Updated: 2008-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
976 participants
INTERVENTIONAL
2002-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xalacom
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pfizer, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Sydney, New South Wales, Australia
Pfizer Investigational Site
Sydney, New South Wales, Australia
Pfizer Investigational Site
Antwerp, , Belgium
Pfizer Investigational Site
Brussels, , Belgium
Pfizer Investigational Site
Edegem, , Belgium
Pfizer Investigational Site
Ghent, , Belgium
Pfizer Investigational Site
Leuven, , Belgium
Pfizer Investigational Site
Liège, , Belgium
Pfizer Investigational Site
København Ø, , Denmark
Pfizer Investigational Site
Odense C, , Denmark
Pfizer Investigational Site
Aire Sur Adour, , France
Pfizer Investigational Site
Carcassonne, , France
Pfizer Investigational Site
Dijon, , France
Pfizer Investigational Site
Figeac, , France
Pfizer Investigational Site
Haguenau, , France
Pfizer Investigational Site
Le Cannet, , France
Pfizer Investigational Site
Loos, , France
Pfizer Investigational Site
Marseille, , France
Pfizer Investigational Site
Paris, , France
Pfizer Investigational Site
Versailles, , France
Pfizer Investigational Site
Erlangen, , Germany
Pfizer Investigational Site
Freising, , Germany
Pfizer Investigational Site
Gerolzhofen, , Germany
Pfizer Investigational Site
Hirschaid, , Germany
Pfizer Investigational Site
Hösbach, , Germany
Pfizer Investigational Site
Mainz, , Germany
Pfizer Investigational Site
Mainz, , Germany
Pfizer Investigational Site
Würzburg, , Germany
Pfizer Investigational Site
Piraeus, Nikea-Piraeus, Greece
Pfizer Investigational Site
Athens, , Greece
Pfizer Investigational Site
Kavala, , Greece
Pfizer Investigational Site
Pátrai, , Greece
Pfizer Investigational Site
Thessaloniki, , Greece
Pfizer Investigational Site
Ennis, Co. Clare, Ireland
Pfizer Investigational Site
Galway, , Ireland
Pfizer Investigational Site
Siena, Siena, Italy
Pfizer Investigational Site
Bologna, , Italy
Pfizer Investigational Site
Florence, , Italy
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Padua, , Italy
Pfizer Investigational Site
Perugia, , Italy
Pfizer Investigational Site
Pisa, , Italy
Pfizer Investigational Site
Torino, , Italy
Pfizer Investigational Site
Alkmaar, , Netherlands
Pfizer Investigational Site
Gouda, , Netherlands
Pfizer Investigational Site
Rijswijk, , Netherlands
Pfizer Investigational Site
Almería, Almeria, Spain
Pfizer Investigational Site
Palma de Mallorca, Balearic Islands, Spain
Pfizer Investigational Site
Badalona, Barcelona, Spain
Pfizer Investigational Site
Barcelona, Barcelona, Spain
Pfizer Investigational Site
Terrassa, Barcelona, Spain
Pfizer Investigational Site
Lugo, Lugo, Spain
Pfizer Investigational Site
Getafe, Madrid, Spain
Pfizer Investigational Site
Madrid, Madrid, Spain
Pfizer Investigational Site
Málaga, Malaga, Spain
Pfizer Investigational Site
Valencia, Valencia, Spain
Pfizer Investigational Site
Valladolid, Valladolid, Spain
Pfizer Investigational Site
Bilbao, Vizcaya, Spain
Pfizer Investigational Site
Zaragoza, Zaragoza, Spain
Pfizer Investigational Site
Motala, , Sweden
Pfizer Investigational Site
Örebro, , Sweden
Pfizer Investigational Site
Stockholm, , Sweden
Pfizer Investigational Site
Uppsala, , Sweden
Pfizer Investigational Site
Västerås, , Sweden
Pfizer Investigational Site
Bristol, Gloucestershire, United Kingdom
Pfizer Investigational Site
Cheltenham, Gloucestershire, United Kingdom
Pfizer Investigational Site
Bolton, Lancs, United Kingdom
Pfizer Investigational Site
Uxbridge, Middlesex, United Kingdom
Pfizer Investigational Site
Norwich, Norfolk, United Kingdom
Pfizer Investigational Site
Redhill, Surrey, United Kingdom
Pfizer Investigational Site
Birmingham, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Lancaster, , United Kingdom
Pfizer Investigational Site
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
912-OPT-0076-019
Identifier Type: -
Identifier Source: org_study_id